The North America drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.

North America Drug Delivery Systems Market Introduction

Over the past few decades, research and development (R&D) in drug delivery devices has been on the rise globally, driven by the increasing prevalence of chronic diseases. Drug delivery refers to the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being explored to effectively treat these chronic conditions. According to the Centers for Disease Control and Prevention (CDC) data from 2019, nearly 6 out of 10 adults in the United States suffered from at least one chronic disease, and 4 out of 10 had two or more. Furthermore, cancer remains a leading cause of mortality in the North American region. The American Cancer Society (ACS) estimated approximately 1,735,350 new cancer cases were diagnosed in 2018. A targeted drug delivery system (TDDS) is engineered to deliver medication in a controlled manner to a specific biological site. Diabetes, a life-threatening chronic disease without a definitive cure, can lead to numerous complications throughout the body and elevate the overall risk of premature death across all its types.  

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005752

North America Drug Delivery Systems Strategic Insights

Strategic insights for the North America Drug Delivery Systems market offer data-driven analysis of the industry landscape, encompassing current trends, key players, and regional specificities. These insights provide actionable recommendations, empowering readers to distinguish themselves from competitors by pinpointing underserved segments or formulating distinctive value propositions. By leveraging data analytics, these insights assist industry participants, including investors, manufacturers, and other stakeholders, in anticipating market shifts. Adopting a future-oriented perspective is crucial, enabling stakeholders to foresee market changes and strategically position themselves for sustained success within this dynamic region. Ultimately, effective strategic insights equip readers to make well-informed decisions that foster profitability and help them achieve their business objectives within the market.  

North America Drug Delivery Systems Market Segmentation

North America Drug Delivery Systems Market: By Route of Administration

  • Transmucosal
  • Oral
  • Injectable
  • Topical
  • Implantable
  • Ocular

North America Drug Delivery Systems Market: By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

North America Drug Delivery Systems Market: By Application

  • Home Care Settings
  • Hospitals & Clinics

North America Drug Delivery Systems Market: Regions and Countries Covered  

North America

  • US
  • Canada
  • Mexico

North America Drug Delivery Systems Market: Market leaders and key company profiles

  • BD
  • Novo Nordisk A/S
  • 3M
  • Boston Scientific Corporation
  • Bausch Health Companies Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications